A study comparing two Ayurvedic medicines Mahatriphaladi Ghrit and Saptamrut Loha Vati for treating early stage short sightedness ( myopia ) in 18 to 30 years age group

A randomized controlled trial on effect of Mahatriphaladi Ghrita Sapta Avarti in comparison with Saptamrut Loha Vati in the treatment of simple myopia w.s.r.to Prathama Patalgata Timira - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/105020

Enrollment

Registered

2026-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Blurring of vision 2. Eye strain 3. Watering of eye 4. Headache 5. Myopia up to the range of -0.25D to -3.00D 6. Patient are willing to give consent for this study

Exclusion criteria

Exclusion criteria: 1. Patient suffering from other ocular diseases 2. Patient suffering from other systemic disease like Hypertension, Diabetes Mellitus, Thyroid 3. Patient not willing for clinical trial

Design outcomes

Primary

Measure	Time frame
1. To Study clinical effect of MAHATRIPHALADI GHRITA SAPTA AVARTI comparison with SAPTAMRUT LOHA VATI in the management of Pratham Patalgat Timir i.e. Simple Myopia with the help of improvement in visual acuity. 2. To evaluate efficacy of MAHATRIPHALADI GHRITA SAPTA AVART in relieving asthenopia symptoms such as eye strain, vison, headache, watering of eye Timepoint: 30 days	—

Secondary

Measure	Time frame
To see the positive effect in reduction of dioptric powerTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Dhananjay Madakwar

Shri Ayurved Mahavidyalaya Nagpur

drgovind2005@gmail.com9860166089

Outcome results